• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
AVCJ
  • North Asia

Bain agrees $3b carve-out from Japan's Olympus

microscope
  • Tim Burroughs
  • 30 August 2022
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Save this article  
  • Send to  

Bain Capital has agreed to acquire Evident, a Japan-based medical devices manufacturer best known for producing microscopes, from Olympus Corporation for JPY 427.7bn (USD 3.08bn).

This is the private equity firm’s seventh announced or completed carve-out of a Japan-based business. An eighth is pending, with a Bain-led consortium having launched a JPY 816.8bn tender offer for Hitachi Metals, after agreeing to buy Hitachi’s majority stake in the business. The firm is also known for leading a JPY 2trn acquisition of Toshiba’s flash memory division.

Olympus has previously demonstrated a willingness to offload non-core assets to private equity buyers. This is its fifth divestment in the past 10 years, following deals involving mobile devices business ITX Corporation, e-commerce payments player Net Protections Holdings, business services platform Nippon Outsourcing, and its imaging division.

The conglomerate said in a filing that the sale of Evident, its scientific solutions division, was driven by a desire to focus on global competitiveness in other areas of medical devices, notably endoscopic and therapeutic solutions.

Evident supplies microscopes to life sciences users for academic and clinical research purposes, pathology diagnostic services, drug discovery, and fertility treatments. Its industrials client base, meanwhile, sources microscopes used in semiconductor and electronic components manufacturing, videoscopes and fiberscopes, non-destructive testing equipment, and x-ray fluorescence analysers.

Sales for the 12 months ended March came to JPY 119.1bn, while operating income reached JPY 17.5bn. Olympus added that, under Bain’s ownership, Evident could develop its business with more agile and flexible decision-making, leading to further growth and product development.

“Bain Capital has a deep understanding of Evident's business value and growth potential. Importantly, they highly appreciate Evident's corporate culture, which has been a valuable asset to Olympus in fulfilling a diverse spectrum of customer needs through the global collaboration and proactive commercialisation of cutting-edge technologies,” said Yasuo Takeuchi, president and CEO of Olympus.

This is the second large-cap corporate carve-out announced in Japan in the past four months, following KKR’s agreement to acquire Hitachi’s controlling stake in Hitachi Transport Systems, which trigged a JPY 749.5bn tender offer for the listed logistics business.

A sale process is also underway for Toshiba – the parent entity rather than one of its divisions – as the beleaguered conglomerate looks for ways to address structural and governance issues. In April, Effissimo Capital Management, an activist investor that owns about 9.9% of the company, said it would sell to Bain should the private equity firm submit an offer that receives regulatory approval.

Bain recently launched its fifth Asia-focused private equity fund with a target of USD 5bn.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Save this article  
  • Send to  
  • Topics
  • North Asia
  • Buyouts
  • Industrials
  • Healthcare
  • Technology
  • Bain Capital Asia
  • Japan
  • manufacturing

More on North Asia

layerx
Japan's LayerX extends Series A to $67.5m
  • North Asia
  • 09 Nov 2023
integral-office
Integral makes partial exit from Japan’s Skymark
  • North Asia
  • 09 Nov 2023
jean-eric-salata-baring-2019
Q&A: BPEA EQT’s Jean Eric Salata
  • GPs
  • 08 Nov 2023
airport-travel
Asia’s LP landscape: North to south
  • LPs
  • 08 Nov 2023

Latest News

world-hands-globe-climate-esg
Asian GPs slow implementation of ESG policies - survey

Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...

  • GPs
  • 10 November 2023
housing-house-home-mortgage
Singapore fintech start-up LXA gets $10m seed round

New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.

  • Southeast Asia
  • 10 November 2023
india-rupee-money-nbfc
India's InCred announces $60m round, claims unicorn status

Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”

  • South Asia
  • 10 November 2023
roller-mark-luke-finn
Insight leads $50m round for Australia's Roller

Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.

  • Australasia
  • 10 November 2023
Back to Top
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013